,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1144466,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,TRPM3,https://www.dgidb.org/genes/TRPM3,,,80036.0,TRPM3,9606.0,Homo sapiens (human),Blocker,,,,,,,
1,1144467,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,CYP19A1,https://www.dgidb.org/genes/CYP19A1,,,1588.0,CYP19A1,9606.0,Homo sapiens (human),,,,,,,,
2,1144468,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,CYP3A4,https://www.dgidb.org/genes/CYP3A4,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),,,,,,,,
3,1235025,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0009091,KAT8 regulatory NSL complex subunit 3,https://www.drugbank.ca/bio_entities/BE0009091,Q9P2N6,KAT8 regulatory NSL complex subunit 3,55683.0,KANSL3,9606.0,Homo sapiens (human),,,,PMID:24412302,https://www.ncbi.nlm.nih.gov/pubmed/24412302,24412302,,"Priscilla DH, Roy D, Suresh A, Kumar V, Thirumurugan K: Naringenin inhibits alpha-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem Biol Interact. 2014 Mar 5;210:77-85. doi: 10.1016/j.cbi.2013.12.014. Epub 2014 Jan 8."
4,1235026,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000685,Sex hormone-binding globulin,https://www.drugbank.ca/bio_entities/BE0000685,P04278,Sex hormone-binding globulin,6462.0,SHBG,9606.0,Homo sapiens (human),,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,"Hong H, Branham WS, Ng HW, Moland CL, Dial SL, Fang H, Perkins R, Sheehan D, Tong W: Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and alpha-fetoprotein. Toxicol Sci. 2015 Feb;143(2):333-48. doi: 10.1093/toxsci/kfu231. Epub 2014 Oct 27."
5,1235027,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0002090,Aromatase,https://www.drugbank.ca/bio_entities/BE0002090,P11511,Aromatase,1588.0,CYP19A1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:9435150,https://www.ncbi.nlm.nih.gov/pubmed/9435150,9435150,,"Kao YC, Zhou C, Sherman M, Laughton CA, Chen S: Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ Health Perspect. 1998 Feb;106(2):85-92."
6,1235028,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0004096,HTH-type transcriptional regulator TtgR,https://www.drugbank.ca/bio_entities/BE0004096,Q9AIU0,HTH-type transcriptional regulator TtgR,,,1196325.0,Pseudomonas putida DOT-T1E,,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42."
7,1235029,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000123,Estrogen receptor,https://www.drugbank.ca/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606.0,Homo sapiens (human),,,,PMID:10397250|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/10397250|https://www.ncbi.nlm.nih.gov/pubmed/9751507,10397250|9751507,,"Hunter DS, Hodges LC, Vonier PM, Fuchs-Young R, Gottardis MM, Walker CL: Estrogen receptor activation via activation function 2 predicts agonism of xenoestrogens in normal and neoplastic cells of the uterine myometrium. Cancer Res. 1999 Jul 1;59(13):3090-9.|Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998 Oct;139(10):4252-63."
8,1235030,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000126,Aldo-keto reductase family 1 member C1,https://www.drugbank.ca/bio_entities/BE0000126,Q04828,Aldo-keto reductase family 1 member C1,1645.0,AKR1C1,9606.0,Homo sapiens (human),Antagonist,,,PMID:16962702,https://www.ncbi.nlm.nih.gov/pubmed/16962702,16962702,,"Brozic P, Smuc T, Gobec S, Rizner TL: Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1. Mol Cell Endocrinol. 2006 Oct 19;259(1-2):30-42. Epub 2006 Sep 8."
9,1235171,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001111,Cytochrome P450 1B1,https://www.drugbank.ca/bio_entities/BE0001111,Q16678,Cytochrome P450 1B1,,,9606.0,Homo sapiens (human),,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,"Shimada T, Tanaka K, Takenaka S, Murayama N, Martin MV, Foroozesh MK, Yamazaki H, Guengerich FP, Komori M: Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chem Res Toxicol. 2010 Dec 20;23(12):1921-35. doi: 10.1021/tx100286d."
10,1235172,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000792,Estrogen receptor beta,https://www.drugbank.ca/bio_entities/BE0000792,Q92731,Estrogen receptor beta,2100.0,ESR2,9606.0,Homo sapiens (human),Partial agonist,,,PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/9751507,9751507,,"Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998 Oct;139(10):4252-63."
11,1235173,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001042,Solute carrier organic anion transporter family member 2B1,https://www.drugbank.ca/bio_entities/BE0001042,O94956,Solute carrier organic anion transporter family member 2B1 ,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15640378,https://www.ncbi.nlm.nih.gov/pubmed/15640378,15640378,,"Satoh H, Yamashita F, Tsujimoto M, Murakami H, Koyabu N, Ohtani H, Sawada Y: Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005 Apr;33(4):518-23. Epub 2005 Jan 7."
12,1235174,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606.0,Homo sapiens (human),Downregulator,,,PMID:9821810|PMID:10583025|PMID:14980703|PMID:25685543,https://www.ncbi.nlm.nih.gov/pubmed/9821810|https://www.ncbi.nlm.nih.gov/pubmed/10583025|https://www.ncbi.nlm.nih.gov/pubmed/14980703|https://www.ncbi.nlm.nih.gov/pubmed/25685543,9821810|10583025|14980703|25685543,,"Takanaga H, Ohnishi A, Matsuo H, Sawada Y: Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol Pharm Bull. 1998 Oct;21(10):1062-6.|Eagling VA, Profit L, Back DJ: Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br J Clin Pharmacol. 1999 Oct;48(4):543-52.|Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ: Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med. 2004 Mar 1;36(5):592-604.|Abdallah HM, Al-Abd AM, El-Dine RS, El-Halawany AM: P-glycoprotein inhibitors of natural origin as potential tumor chemo-sensitizers: A review. J Adv Res. 2015 Jan;6(1):45-62. doi: 10.1016/j.jare.2014.11.008. Epub 2014 Dec 1."
13,1235175,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0000785,Multidrug resistance-associated protein 1,https://www.drugbank.ca/bio_entities/BE0000785,P33527,Multidrug resistance-associated protein 1 ,4363.0,ABCC1,9606.0,Homo sapiens (human),Inhibitor,,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,"Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SP: Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol. 2001 May;59(5):1171-80."
14,1235176,439246,DrugBank,Naringenin,DB03467,Naringenin,https://www.drugbank.ca/drugs/DB03467,BE0001067,ATP-binding cassette sub-family G member 2,https://www.drugbank.ca/bio_entities/BE0001067,Q9UNQ0,Broad substrate specificity ATP-binding cassette transporter ABCG2,9429.0,ABCG2,9606.0,Homo sapiens (human),Inhibitor,,,PMID:15102949|PMID:15205350,https://www.ncbi.nlm.nih.gov/pubmed/15102949|https://www.ncbi.nlm.nih.gov/pubmed/15205350,15102949|15205350,,"Zhang S, Yang X, Morris ME: Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. Mol Pharmacol. 2004 May;65(5):1208-16.|Imai Y, Tsukahara S, Asada S, Sugimoto Y: Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance. Cancer Res. 2004 Jun 15;64(12):4346-52."
15,1235177,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,GLO1,https://www.dgidb.org/genes/GLO1,,,2739.0,GLO1,9606.0,Homo sapiens (human),,,,,,,,
16,1268339,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of daunorubicin]]|naringenin inhibits the reaction [ABCB1 protein results in decreased uptake of daunorubicin]|naringenin promotes the reaction [elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of rhodamine 123]],,,PMID:34217736,https://www.ncbi.nlm.nih.gov/pubmed/34217736,34217736,,
17,1268340,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606.0,Homo sapiens (human),Naringenin results in increased expression of ABCB1 mRNA,,,PMID:19148864,https://www.ncbi.nlm.nih.gov/pubmed/19148864,19148864,,
18,1268341,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),[glutathione co-treated with naringenin] inhibits the reaction [ABCC1 protein results in increased uptake of estradiol-17 beta-glucuronide]|naringenin results in increased activity of ABCC1 protein|glutathione promotes the reaction [naringenin results in increased activity of ABCC1 protein]|glutathione promotes the reaction [naringenin affects the reaction [ABCC1 protein results in increased uptake of leukotriene c4]]|naringenin affects the reaction [ABCC1 protein results in increased uptake of leukotriene C4],,,PMID:11306701,https://www.ncbi.nlm.nih.gov/pubmed/11306701,11306701,,
19,1268342,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),"Naringenin promotes the reaction [ABCC1 protein results in increased hydrolysis of adenosine triphosphate]|naringenin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione]|naringenin inhibits the reaction [ABCC1 protein results in decreased susceptibility to etoposide]",,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
20,1268343,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4363,ABCC1,https://ctdbase.org/detail.go?type=gene&acc=4363,,,4363.0,ABCC1,9606.0,Homo sapiens (human),Naringenin promotes the reaction [ABCC1 protein results in increased uptake of glutathione],,,PMID:12485947,https://www.ncbi.nlm.nih.gov/pubmed/12485947,12485947,,
21,1268498,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased expression of CPT1A mrna],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
22,1268499,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10257,ABCC4,https://ctdbase.org/detail.go?type=gene&acc=10257,,,10257.0,ABCC4,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [ABCC4 protein results in increased export of cyclic gmp]|naringenin promotes the reaction [ABCC4 protein results in increased hydrolysis of adenosine triphosphate],,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
23,1268500,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10057,ABCC5,https://ctdbase.org/detail.go?type=gene&acc=10057,,,10057.0,ABCC5,9606.0,Homo sapiens (human),"Naringenin inhibits the reaction [ABCC5 protein results in decreased susceptibility to thioguanine]|naringenin inhibits the reaction [ABCC5 protein results in increased export of 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein]",,,PMID:16156793,https://www.ncbi.nlm.nih.gov/pubmed/16156793,16156793,,
24,1268501,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,9986.0,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the activity of ACAT1 protein",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
25,1268502,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,8005.0,Electrophorus electricus (electric eel),Naringenin results in decreased activity of ACHE protein,,,PMID:31194956,https://www.ncbi.nlm.nih.gov/pubmed/31194956,31194956,,
26,1268503,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,9606.0,Homo sapiens (human),Naringenin results in decreased activity of ACHE protein,,,PMID:14739537,https://www.ncbi.nlm.nih.gov/pubmed/14739537,14739537,,
27,1268504,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dimethylnitrosamine results in increased expression of ACTA2 protein],,,PMID:14709902,https://www.ncbi.nlm.nih.gov/pubmed/14709902,14709902,,
28,1268505,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,575,ADGRB1,https://ctdbase.org/detail.go?type=gene&acc=575,,,575.0,ADGRB1,9606.0,Homo sapiens (human),Naringenin metabolite results in increased expression of ADGRB1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of ADGRB1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of ADGRB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
29,1268506,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,174,AFP,https://ctdbase.org/detail.go?type=gene&acc=174,,,174.0,AFP,10116.0,Rattus norvegicus (Norway rat),Naringenin binds to AFP protein,,,PMID:23013281|PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/23013281|https://www.ncbi.nlm.nih.gov/pubmed/25349334,23013281|25349334,,
30,1268507,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]]|naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of AHR protein],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
31,1268655,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,10090.0,Mus musculus (house mouse),Naringenin results in increased activity of AHR protein,,,PMID:17869316,https://www.ncbi.nlm.nih.gov/pubmed/17869316,17869316,,
32,1268656,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196.0,AHR,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased activity of AHR protein],,,PMID:14646185,https://www.ncbi.nlm.nih.gov/pubmed/14646185,14646185,,
33,1268657,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606.0,Homo sapiens (human),Naringenin binds to and results in decreased activity of AKR1C1 protein,,,PMID:16962702,https://www.ncbi.nlm.nih.gov/pubmed/16962702,16962702,,
34,1268658,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606.0,Homo sapiens (human),Naringenin results in decreased activity of AKR1C3 protein,,,PMID:19007764,https://www.ncbi.nlm.nih.gov/pubmed/19007764,19007764,,
35,1268659,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [bisphenol A results in increased activity of AKT1 protein],,,PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/22692793,22692793,,
36,1268660,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of AKT1 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
37,1268661,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10044.0,Phodopus sungorus,Naringenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein],,,PMID:22850125,https://www.ncbi.nlm.nih.gov/pubmed/22850125,22850125,,
38,1268662,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
39,1268663,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,213,ALB,https://ctdbase.org/detail.go?type=gene&acc=213,,,213.0,ALB,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in increased expression of ALB protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
40,1268664,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein]|[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein,,,PMID:12650720,https://www.ncbi.nlm.nih.gov/pubmed/12650720,12650720,,
41,1268811,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of APAF1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of APAF1 mrna|naringenin metabolite results in increased expression of APAF1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
42,1268812,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,317,APAF1,https://ctdbase.org/detail.go?type=gene&acc=317,,,317.0,APAF1,9606.0,Homo sapiens (human),Naringenin results in increased expression of APAF1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
43,1268813,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [APP protein modified form results in increased abundance of reactive oxygen species],,,PMID:15030205,https://www.ncbi.nlm.nih.gov/pubmed/15030205,15030205,,
44,1268814,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,358,AQP1,https://ctdbase.org/detail.go?type=gene&acc=358,,,358.0,AQP1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP1 mrna]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP1 protein],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
45,1268815,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,362,AQP5,https://ctdbase.org/detail.go?type=gene&acc=362,,,362.0,AQP5,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP5 mrna]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of AQP5 protein],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
46,1268816,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,396,ARHGDIA,https://ctdbase.org/detail.go?type=gene&acc=396,,,396.0,ARHGDIA,9606.0,Homo sapiens (human),Naringenin results in increased expression of ARHGDIA protein|naringenin results in increased expression of ARHGDIA mRNA,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
47,1268817,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,405,ARNT,https://ctdbase.org/detail.go?type=gene&acc=405,,,405.0,ARNT,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of ARNT protein]|naringenin inhibits the reaction [tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ARNT protein]],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
48,1268818,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,472,ATM,https://ctdbase.org/detail.go?type=gene&acc=472,,,472.0,ATM,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of ATM mrna|[naringenin co-treated with bisphenol A] results in increased expression of ATM mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
49,1268819,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,545,ATR,https://ctdbase.org/detail.go?type=gene&acc=545,,,545.0,ATR,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of ATR mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of ATR mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
50,1268951,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,23621,BACE1,https://ctdbase.org/detail.go?type=gene&acc=23621,,,23621.0,BACE1,9606.0,Homo sapiens (human),Naringenin results in decreased activity of BACE1 protein,,,PMID:31194956,https://www.ncbi.nlm.nih.gov/pubmed/31194956,31194956,,
51,1268952,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606.0,Homo sapiens (human),Naringenin results in increased expression of BAK1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
52,1268953,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased expression of BAX protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
53,1268954,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),Naringenin results in decreased expression of BAX mrna|tamoxifen promotes the reaction [naringenin results in decreased expression of BAX mrna]|naringenin inhibits the reaction [tamoxifen results in decreased expression of BAX mrna],,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
54,1268955,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BAX mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
55,1268956,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of BAX protein]|naringenin inhibits the reaction [glucose results in increased expression of BAX mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
56,1268957,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of BBC3 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of BBC3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
57,1268958,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,590,BCHE,https://ctdbase.org/detail.go?type=gene&acc=590,,,590.0,BCHE,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [[tritolyl phosphates co-treated with NADP] results in decreased activity of BCHE protein],,,PMID:23085349,https://www.ncbi.nlm.nih.gov/pubmed/23085349,23085349,,
58,1268959,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),BCL2 protein results in decreased susceptibility to naringenin|ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin],,,PMID:19124070,https://www.ncbi.nlm.nih.gov/pubmed/19124070,19124070,,
59,1268960,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BCL2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
60,1269096,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in decreased expression of BCL2 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
61,1269097,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Naringenin promotes the reaction [tamoxifen results in decreased expression of BCL2 mrna],,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
62,1269098,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606.0,Homo sapiens (human),Naringenin results in decreased expression of BCL2 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
63,1269099,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of BCL2 mrna]|naringenin inhibits the reaction [glucose results in decreased expression of BCL2 protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
64,1269100,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,597,BCL2A1,https://ctdbase.org/detail.go?type=gene&acc=597,,,597.0,BCL2A1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mrna|naringenin metabolite results in increased expression of BCL2A1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
65,1269101,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of BCL2L1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
66,1269102,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116.0,Rattus norvegicus (Norway rat),Naringenin results in increased expression of BDNF mrna|naringenin inhibits the reaction [paraquat results in decreased expression of BDNF mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
67,1269103,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332.0,BIRC5,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BIRC5 mrna|naringenin metabolite results in increased expression of BIRC5 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BIRC5 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
68,1269104,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,672,BRCA1,https://ctdbase.org/detail.go?type=gene&acc=672,,,672.0,BRCA1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BRCA1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
69,1269105,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,675,BRCA2,https://ctdbase.org/detail.go?type=gene&acc=675,,,675.0,BRCA2,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of BRCA2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of BRCA2 mrna|naringenin results in increased expression of BRCA2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
70,1269287,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7832,BTG2,https://ctdbase.org/detail.go?type=gene&acc=7832,,,7832.0,BTG2,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of BTG2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of BTG2 mrna|naringenin metabolite results in decreased expression of BTG2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
71,1269288,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835.0,CASP2,9606.0,Homo sapiens (human),Naringenin results in increased expression of CASP2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CASP2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CASP2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
72,1269289,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased activity of CASP3 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
73,1269290,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Naringenin results in increased activity of CASP3 protein,,,PMID:19124070|PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/19124070|https://www.ncbi.nlm.nih.gov/pubmed/22692793,19124070|22692793,,
74,1269291,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,9606.0,Homo sapiens (human),Naringenin results in increased expression of CASP3 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
75,1269292,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of CASP3 mrna]|naringenin inhibits the reaction [glucose results in increased expression of and results in increased cleavage of CASP3 protein]|naringenin inhibits the reaction [glucose results in increased activity of CASP3 protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
76,1269293,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116.0,Rattus norvegicus (Norway rat),Naringenin results in increased expression of CASP3 mrna|naringenin inhibits the reaction [paraquat results in increased expression of CASP3 mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
77,1269294,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840.0,CASP7,9606.0,Homo sapiens (human),Naringenin results in increased expression of CASP7 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
78,1269295,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CASP9 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CASP9 mrna|naringenin results in increased expression of CASP9 mrna|naringenin metabolite results in increased expression of CASP9 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
79,1269429,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased activity of CASP9 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
80,1269430,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Naringenin results in increased activity of CASP9 protein,,,PMID:19124070,https://www.ncbi.nlm.nih.gov/pubmed/19124070,19124070,,
81,1269431,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,9606.0,Homo sapiens (human),Naringenin results in increased expression of CASP9 protein modified form,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
82,1269432,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of CASP9 mrna]|naringenin inhibits the reaction [glucose results in increased expression of and results in increased cleavage of CASP9 protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
83,1269433,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in decreased activity of CAT protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
84,1269434,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10090.0,Mus musculus (house mouse),Naringenin results in decreased expression of CAT protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
85,1269435,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin analog results in increased activity of CAT protein,,,PMID:27417253,https://www.ncbi.nlm.nih.gov/pubmed/27417253,27417253,,
86,1269436,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [arsenic trioxide results in decreased activity of CAT protein],,,PMID:23283742,https://www.ncbi.nlm.nih.gov/pubmed/23283742,23283742,,
87,1269437,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of CAT protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
88,1269438,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium results in decreased activity of CAT protein],,,PMID:19409769,https://www.ncbi.nlm.nih.gov/pubmed/19409769,19409769,,
89,1269585,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased activity of CAT protein],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
90,1269586,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased activity of CAT protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
91,1269587,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in increased activity of CAT protein]|naringenin results in increased activity of CAT protein,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
92,1269588,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased activity of CAT protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
93,1269589,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9986.0,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the expression of CCL2 mRNA",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
94,1269590,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of CCL2]],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
95,1269591,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
96,1269592,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of CCND1 mrna|naringenin results in decreased expression of CCND1 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
97,1269593,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNE1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CCNE1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
98,1269594,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898.0,CCNE1,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of CCNE1 mrna|naringenin results in decreased expression of CCNE1 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
99,1269744,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in decreased expression of CCNG1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
100,1269745,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,902,CCNH,https://ctdbase.org/detail.go?type=gene&acc=902,,,902.0,CCNH,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CCNH mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
101,1269746,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,993,CDC25A,https://ctdbase.org/detail.go?type=gene&acc=993,,,993.0,CDC25A,9606.0,Homo sapiens (human),Naringenin metabolite results in increased expression of CDC25A mrna|[naringenin co-treated with bisphenol A] results in increased expression of CDC25A mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDC25A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
102,1269747,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,995,CDC25C,https://ctdbase.org/detail.go?type=gene&acc=995,,,995.0,CDC25C,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDC25C mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDC25C mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
103,1269748,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,983,CDK1,https://ctdbase.org/detail.go?type=gene&acc=983,,,983.0,CDK1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in decreased expression of CDK1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDK1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
104,1269749,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDK4 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
105,1269750,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CDKN1A mrna|naringenin metabolite results in increased expression of CDKN1A mrna|[naringenin co-treated with bisphenol A] results in increased expression of CDKN1A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
106,1269751,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in increased expression of CDKN1A mrna|naringenin results in increased expression of CDKN1A mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
107,1269752,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CDKN2A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
108,1269753,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1080,CFTR,https://ctdbase.org/detail.go?type=gene&acc=1080,,,1080.0,CFTR,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of CFTR mrna]|naringenin inhibits the reaction [[vehicle emissions results in increased abundance of particulate matter] which results in decreased expression of CFTR protein],,,PMID:31301536,https://www.ncbi.nlm.nih.gov/pubmed/31301536,31301536,,
109,1269885,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1111,CHEK1,https://ctdbase.org/detail.go?type=gene&acc=1111,,,1111.0,CHEK1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of CHEK1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of CHEK1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
110,1269886,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,11200,CHEK2,https://ctdbase.org/detail.go?type=gene&acc=11200,,,11200.0,CHEK2,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of CHEK2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CHEK2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
111,1269887,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8738,CRADD,https://ctdbase.org/detail.go?type=gene&acc=8738,,,8738.0,CRADD,9606.0,Homo sapiens (human),Naringenin results in increased expression of CRADD mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of CRADD mrna|[naringenin co-treated with bisphenol A] results in increased expression of CRADD mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
112,1269888,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased expression of CTNNB1 mrna|naringenin inhibits the reaction [paraquat results in decreased expression of CTNNB1 mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
113,1269889,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1509,CTSD,https://ctdbase.org/detail.go?type=gene&acc=1509,,,1509.0,CTSD,9606.0,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of CTSD mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
114,1269890,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576.0,CXCL8,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of CXCL8 protein],,,PMID:19135038,https://www.ncbi.nlm.nih.gov/pubmed/19135038,19135038,,
115,1269891,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,9606.0,Homo sapiens (human),Naringenin results in increased expression of CYCS protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
116,1269892,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose affects the localization of CYCS protein],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
117,1269893,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606.0,Homo sapiens (human),Naringenin binds to and results in decreased activity of CYP19A1 protein,,,PMID:9435150,https://www.ncbi.nlm.nih.gov/pubmed/9435150,9435150,,
118,1269894,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP19A1 protein,,,PMID:15319488,https://www.ncbi.nlm.nih.gov/pubmed/15319488,15319488,,
119,1270051,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of CYP19A1 protein,,,PMID:17895526,https://www.ncbi.nlm.nih.gov/pubmed/17895526,17895526,,
120,1270052,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Naringenin binds to and results in decreased activity of CYP1A1 protein|naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased expression of CYP1A1 mrna],,,PMID:11454723,https://www.ncbi.nlm.nih.gov/pubmed/11454723,11454723,,
121,1270053,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP1A1 protein,,,PMID:21053930|PMID:27444380,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/27444380,21053930|27444380,,
122,1270054,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of CYP1A1 mrna|naringenin promotes the reaction [beta-naphthoflavone results in increased expression of CYP1A1 mrna],,,PMID:20930378,https://www.ncbi.nlm.nih.gov/pubmed/20930378,20930378,,
123,1270055,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of CYP1A1 protein,,,PMID:27444380,https://www.ncbi.nlm.nih.gov/pubmed/27444380,27444380,,
124,1270056,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP1A2 protein,,,PMID:21053930|PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/29753067,21053930|29753067,,
125,1270057,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),Naringenin binds to and results in decreased activity of CYP1B1 protein,,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
126,1270058,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of CYP1B1 mRNA,,,PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/31621310,31621310,,
127,1270059,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP2C19 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
128,1270060,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [CYP2C9 protein results in increased hydroxylation of flurbiprofen],,,PMID:21053930,https://www.ncbi.nlm.nih.gov/pubmed/21053930,21053930,,
129,1270219,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP2C9 protein,,,PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/29753067,29753067,,
130,1270220,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP2E1 protein,,,PMID:33007396,https://www.ncbi.nlm.nih.gov/pubmed/33007396,33007396,,
131,1270221,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Naringenin results in decreased activity of CYP3A4 protein,,,PMID:21053930|PMID:29753067,https://www.ncbi.nlm.nih.gov/pubmed/21053930|https://www.ncbi.nlm.nih.gov/pubmed/29753067,21053930|29753067,,
132,1270222,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606.0,Homo sapiens (human),Naringenin results in increased expression of CYP3A4 mRNA,,,PMID:19148864,https://www.ncbi.nlm.nih.gov/pubmed/19148864,19148864,,
133,1270223,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,79758,DHRS12,https://ctdbase.org/detail.go?type=gene&acc=79758,,,79758.0,DHRS12,9606.0,Homo sapiens (human),Naringenin results in decreased expression of DHRS12 mrna|naringenin results in decreased expression of DHRS12 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
134,1270224,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786.0,DNMT1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of DNMT1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of DNMT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
135,1270225,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1813,DRD2,https://ctdbase.org/detail.go?type=gene&acc=1813,,,1813.0,DRD2,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased expression of DRD2 mrna|naringenin inhibits the reaction [paraquat results in decreased expression of DRD2 mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
136,1270226,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1869,E2F1,https://ctdbase.org/detail.go?type=gene&acc=1869,,,1869.0,E2F1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of E2F1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of E2F1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
137,1270227,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1871,E2F3,https://ctdbase.org/detail.go?type=gene&acc=1871,,,1871.0,E2F3,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of E2F3 mrna|[naringenin co-treated with bisphenol A] results in increased expression of E2F3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
138,1270228,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of EGFR mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of EGFR mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
139,1270371,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of EGFR protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
140,1270372,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of EGR1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of EGR1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
141,1270373,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,28377.0,Anolis carolinensis (green anole),Naringenin binds to ESR1 protein,,,PMID:11162928,https://www.ncbi.nlm.nih.gov/pubmed/11162928,11162928,,
142,1270374,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,7957.0,Carassius auratus (goldfish),Naringenin results in increased activity of ESR1 protein,,,PMID:18980245,https://www.ncbi.nlm.nih.gov/pubmed/18980245,18980245,,
143,1270375,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein]|[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein,,,PMID:12650720,https://www.ncbi.nlm.nih.gov/pubmed/12650720,12650720,,
144,1270376,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin affects the activity of ESR1 protein,,,PMID:15185748,https://www.ncbi.nlm.nih.gov/pubmed/15185748,15185748,,
145,1270377,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin binds to and results in increased activity of ESR1 protein,,,PMID:10397250|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/10397250|https://www.ncbi.nlm.nih.gov/pubmed/9751507,10397250|9751507,,
146,1270378,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin binds to ESR1 protein,,,PMID:19913605|PMID:22692793,https://www.ncbi.nlm.nih.gov/pubmed/19913605|https://www.ncbi.nlm.nih.gov/pubmed/22692793,19913605|22692793,,
147,1270379,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of ESR1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of ESR1 mrna|naringenin metabolite results in increased expression of ESR1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
148,1270380,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,9606.0,Homo sapiens (human),[paraquat co-treated with naringenin] results in increased expression of GPX3 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
149,1270518,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of CTSD mrna|[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PGR mrna|naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein|naringenin inhibits the reaction [estradiol results in decreased expression of ESR1 protein]|[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PSEN2 mrna|naringenin inhibits the reaction [cycloheximide results in decreased expression of ESR1 protein]|[sb 203580 co-treated with naringenin] results in increased degradation of ESR1 protein|naringenin results in decreased expression of ESR1 mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
150,1270519,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin promotes the reaction [ESR1 protein binds to ESR1 protein],,,PMID:15713566,https://www.ncbi.nlm.nih.gov/pubmed/15713566,15713566,,
151,1270520,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of ESR1 mRNA alternative form|naringenin results in decreased expression of ESR1 protein alternative form|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mRNA alternative form|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 mrna|naringenin results in increased expression of ESR1 mrna|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein alternative form|[tamoxifen co-treated with naringenin] results in decreased expression of ESR1 protein,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
152,1270521,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606.0,Homo sapiens (human),Naringenin results in increased activity of ESR1 protein,,,PMID:10854714|PMID:16118406,https://www.ncbi.nlm.nih.gov/pubmed/10854714|https://www.ncbi.nlm.nih.gov/pubmed/16118406,10854714|16118406,,
153,1270522,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,10090.0,Mus musculus (house mouse),Naringenin binds to ESR1 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
154,1270523,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Bisphenol A inhibits the reaction [naringenin metabolite results in increased expression of ESR2 mrna]|naringenin metabolite results in increased expression of ESR2 mrna|bisphenol A inhibits the reaction [naringenin results in increased expression of ESR2 mrna],,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
155,1270524,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Naringenin binds to and results in increased activity of ESR2 protein,,,PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/9751507,9751507,,
156,1270525,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Naringenin binds to ESR2 protein,,,PMID:12224631|PMID:16566672|PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/12224631|https://www.ncbi.nlm.nih.gov/pubmed/16566672|https://www.ncbi.nlm.nih.gov/pubmed/19913605,12224631|16566672|19913605,,
157,1270673,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [estradiol binds to ESR2 protein],,,PMID:16566672|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/16566672|https://www.ncbi.nlm.nih.gov/pubmed/9751507,16566672|9751507,,
158,1270674,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Naringenin results in increased activity of ESR2 protein,,,PMID:16118406|PMID:17716812,https://www.ncbi.nlm.nih.gov/pubmed/16118406|https://www.ncbi.nlm.nih.gov/pubmed/17716812,16118406|17716812,,
159,1270675,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),Naringenin results in increased expression of ESR2 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
160,1270676,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in increased expression of ESR2 protein|[tamoxifen co-treated with naringenin] results in increased expression of ESR2 mrna|naringenin results in increased expression of ESR2 protein,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
161,1270677,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,10090.0,Mus musculus (house mouse),Naringenin binds to ESR2 protein,,,PMID:19913605,https://www.ncbi.nlm.nih.gov/pubmed/19913605,19913605,,
162,1270678,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8772,FADD,https://ctdbase.org/detail.go?type=gene&acc=8772,,,8772.0,FADD,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of FADD mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
163,1270679,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,355,FAS,https://ctdbase.org/detail.go?type=gene&acc=355,,,355.0,FAS,9606.0,Homo sapiens (human),Naringenin metabolite results in increased expression of FAS mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of FAS mrna|[naringenin co-treated with bisphenol A] results in increased expression of FAS mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
164,1270680,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
165,1270681,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of FASLG mrna|naringenin metabolite results in increased expression of FASLG mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of FASLG mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
166,1270682,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2353,FOS,https://ctdbase.org/detail.go?type=gene&acc=2353,,,2353.0,FOS,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of FOS mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
167,1270810,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2309,FOXO3,https://ctdbase.org/detail.go?type=gene&acc=2309,,,2309.0,FOXO3,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of FOXO3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
168,1270811,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,9606.0,Homo sapiens (human),Naringenin results in decreased activity of G6PD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
169,1270812,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of G6PD protein|[naringenin co-treated with lead acetate] results in decreased activity of G6PD protein,,,PMID:25228019,https://www.ncbi.nlm.nih.gov/pubmed/25228019,25228019,,
170,1270813,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2539,G6PD,https://ctdbase.org/detail.go?type=gene&acc=2539,,,2539.0,G6PD,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of G6PD protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
171,1270814,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1647,GADD45A,https://ctdbase.org/detail.go?type=gene&acc=1647,,,1647.0,GADD45A,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of GADD45A mrna|naringenin metabolite results in increased expression of GADD45A mrna|[naringenin co-treated with bisphenol A] results in increased expression of GADD45A mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
172,1270815,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,9606.0,Homo sapiens (human),Naringenin results in increased expression of GCLC protein|nfe2l2 protein affects the reaction [naringenin results in increased expression of GCLC protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
173,1270816,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606.0,Homo sapiens (human),Naringenin results in increased expression of GCLM protein|nfe2l2 protein affects the reaction [naringenin results in increased expression of GCLM protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
174,1270817,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2765,GML,https://ctdbase.org/detail.go?type=gene&acc=2765,,,2765.0,GML,9606.0,Homo sapiens (human),Naringenin metabolite results in increased expression of GML mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of GML mrna|[naringenin co-treated with bisphenol A] results in increased expression of GML mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
175,1270818,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606.0,Homo sapiens (human),Naringenin metabolite results in decreased expression of GPER1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
176,1270819,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of GPER1 mRNA,,,PMID:30153467|PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/30153467|https://www.ncbi.nlm.nih.gov/pubmed/36235125,30153467|36235125,,
177,1270959,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2852,GPER1,https://ctdbase.org/detail.go?type=gene&acc=2852,,,2852.0,GPER1,9606.0,Homo sapiens (human),[tamoxifen co-treated with naringenin] results in decreased expression of GPER1 protein|naringenin results in decreased expression of GPER1 protein|[tamoxifen co-treated with naringenin] results in decreased expression of GPER1 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
178,1270960,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [arsenic trioxide results in increased activity of GPT protein],,,PMID:23283742,https://www.ncbi.nlm.nih.gov/pubmed/23283742,23283742,,
179,1270961,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875.0,GPT,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in increased activity of GPT protein],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
180,1270962,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10090.0,Mus musculus (house mouse),Naringenin results in decreased expression of GPX1 protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
181,1270963,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2876,GPX1,https://ctdbase.org/detail.go?type=gene&acc=2876,,,2876.0,GPX1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of GPX1 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
182,1270964,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2877,GPX2,https://ctdbase.org/detail.go?type=gene&acc=2877,,,2877.0,GPX2,9606.0,Homo sapiens (human),Naringenin results in increased expression of GPX2 mrna|[paraquat co-treated with naringenin] results in increased expression of GPX2 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
183,1270965,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2880,GPX5,https://ctdbase.org/detail.go?type=gene&acc=2880,,,2880.0,GPX5,9606.0,Homo sapiens (human),Naringenin results in increased expression of GPX5 mrna|[paraquat co-treated with naringenin] results in increased expression of GPX5 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
184,1270966,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2882,GPX7,https://ctdbase.org/detail.go?type=gene&acc=2882,,,2882.0,GPX7,9606.0,Homo sapiens (human),Naringenin results in increased expression of GPX7 mrna|[paraquat co-treated with naringenin] results in increased expression of GPX7 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
185,1270967,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,9606.0,Homo sapiens (human),Naringenin results in increased expression of GSR mrna|paraquat inhibits the reaction [naringenin results in increased expression of GSR mrna],,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
186,1270968,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [cadmium chloride results in decreased expression of GSR protein],,,PMID:19063931,https://www.ncbi.nlm.nih.gov/pubmed/19063931,19063931,,
187,1271105,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of GSR mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
188,1271106,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,2954,GSTZ1,https://ctdbase.org/detail.go?type=gene&acc=2954,,,2954.0,GSTZ1,9606.0,Homo sapiens (human),Naringenin results in increased expression of GSTZ1 mrna|paraquat inhibits the reaction [naringenin results in increased expression of GSTZ1 mrna],,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
189,1271107,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in increased expression of HAVCR1 protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
190,1271108,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3099,HK2,https://ctdbase.org/detail.go?type=gene&acc=3099,,,3099.0,HK2,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of HK2 mrna|naringenin metabolite results in increased expression of HK2 mrna|[naringenin co-treated with bisphenol A] results in increased expression of HK2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
191,1271109,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606.0,Homo sapiens (human),Naringenin results in increased expression of HMOX1 protein|[paraquat co-treated with naringenin] results in increased expression of HMOX1 mrna|naringenin results in increased expression of HMOX1 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
192,1271110,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090.0,Mus musculus (house mouse),"Naringenin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of HMOX1 protein]|naringenin results in increased expression of HMOX1 protein",,,PMID:15316927,https://www.ncbi.nlm.nih.gov/pubmed/15316927,15316927,,
193,1271111,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116.0,Rattus norvegicus (Norway rat),Naringenin results in increased expression of and results in increased activity of HMOX1 protein|wortmannin inhibits the reaction [naringenin results in increased expression of HMOX1 protein]|naringenin inhibits the reaction [TNF protein results in decreased expression of and results in decreased activity of HMOX1 protein]|naringenin results in increased expression of HMOX1 mrna|naringenin inhibits the reaction [TNF protein results in decreased expression of HMOX1 mrna]|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naringenin results in increased expression of HMOX1 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
194,1271112,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of IGF1R mrna|[naringenin co-treated with bisphenol A] results in increased expression of IGF1R mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
195,1271113,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of IKBKB mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
196,1271287,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of IL6 mrna|naringenin metabolite results in increased expression of IL6 mrna|[naringenin co-treated with bisphenol A] results in increased expression of IL6 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
197,1271288,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606.0,Homo sapiens (human),Naringenin results in decreased susceptibility to IL6 protein|naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of ccl2]]|naringenin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
198,1271289,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333.0,Ins1,10044.0,Phodopus sungorus,Naringenin inhibits the reaction [INS1 protein results in increased phosphorylation of AKT1 protein],,,PMID:22850125,https://www.ncbi.nlm.nih.gov/pubmed/22850125,22850125,,
199,1271290,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,9606.0,Homo sapiens (human),Naringenin metabolite results in decreased expression of JUN mrna|naringenin results in decreased expression of JUN mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
200,1271291,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of JUN mRNA,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
201,1271292,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8850,KAT2B,https://ctdbase.org/detail.go?type=gene&acc=8850,,,8850.0,KAT2B,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of KAT2B mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of KAT2B mrna|naringenin metabolite results in increased expression of KAT2B mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
202,1271293,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606.0,Homo sapiens (human),Naringenin promotes the reaction [dofetilide results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [quinidine results in decreased activity of KCNH2 protein]|azimilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|quinidine promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|dofetilide promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|naringenin results in decreased activity of KCNH2 protein|amiodarone promotes the reaction [naringenin results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [azimilide results in decreased activity of KCNH2 protein]|naringenin promotes the reaction [amiodarone results in decreased activity of KCNH2 protein],,,PMID:18057881,https://www.ncbi.nlm.nih.gov/pubmed/18057881,18057881,,
203,1271294,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,3845,KRAS,https://ctdbase.org/detail.go?type=gene&acc=3845,,,3845.0,KRAS,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of KRAS mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
204,1271295,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4025,LPO,https://ctdbase.org/detail.go?type=gene&acc=4025,,,4025.0,LPO,9606.0,Homo sapiens (human),Paraquat inhibits the reaction [naringenin results in increased expression of LPO mrna]|naringenin results in increased expression of LPO mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
205,1271444,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,80313,LRRC27,https://ctdbase.org/detail.go?type=gene&acc=80313,,,80313.0,LRRC27,9606.0,Homo sapiens (human),Naringenin results in increased expression of LRRC27 protein|naringenin results in increased expression of LRRC27 mRNA,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
206,1271445,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,120892,LRRK2,https://ctdbase.org/detail.go?type=gene&acc=120892,,,120892.0,LRRK2,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of LRRK2 mrna]|naringenin results in decreased expression of LRRK2 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
207,1271446,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4217,MAP3K5,https://ctdbase.org/detail.go?type=gene&acc=4217,,,4217.0,MAP3K5,9606.0,Homo sapiens (human),Naringenin results in increased expression of MAP3K5 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
208,1271447,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of MAPK1 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
209,1271448,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Naringenin results in decreased activity of MAPK1 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
210,1271449,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606.0,Homo sapiens (human),Naringenin results in decreased phosphorylation of MAPK1 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
211,1271450,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of MAPK1 protein],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
212,1271451,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
213,1271452,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased phosphorylation of MAPK3 protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
214,1271453,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Naringenin results in decreased activity of MAPK3 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
215,1271600,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606.0,Homo sapiens (human),Naringenin results in decreased phosphorylation of MAPK3 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
216,1271601,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [tetrachlorodibenzodioxin results in increased phosphorylation of MAPK3 protein],,,PMID:20450880,https://www.ncbi.nlm.nih.gov/pubmed/20450880,20450880,,
217,1271602,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606.0,Homo sapiens (human),Naringenin results in increased phosphorylation of MAPK8 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
218,1271603,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,9606.0,Homo sapiens (human),Naringenin results in increased phosphorylation of MAPK9 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
219,1271604,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4170,MCL1,https://ctdbase.org/detail.go?type=gene&acc=4170,,,4170.0,MCL1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MCL1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of MCL1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
220,1271605,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of MDM2 mrna|naringenin metabolite results in increased expression of MDM2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
221,1271606,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4194,MDM4,https://ctdbase.org/detail.go?type=gene&acc=4194,,,4194.0,MDM4,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of MDM4 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MDM4 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
222,1271607,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,406933,MIR141,https://ctdbase.org/detail.go?type=gene&acc=406933,,,406933.0,MIR141,9606.0,Homo sapiens (human),Naringenin metabolite results in decreased expression of MIR141 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
223,1271608,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,406985,MIR200C,https://ctdbase.org/detail.go?type=gene&acc=406985,,,406985.0,MIR200C,9606.0,Homo sapiens (human),Naringenin metabolite inhibits the reaction [bisphenol A results in increased expression of MIR200C mrna]|naringenin inhibits the reaction [bisphenol A results in increased expression of MIR200C mrna],,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
224,1271609,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4292,MLH1,https://ctdbase.org/detail.go?type=gene&acc=4292,,,4292.0,MLH1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of MLH1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MLH1 mrna|naringenin results in increased expression of MLH1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
225,1271774,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Naringenin results in decreased expression of and results in decreased activity of MMP2 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
226,1271775,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313.0,MMP2,9606.0,Homo sapiens (human),Naringenin results in decreased expression of MMP2 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
227,1271776,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased activity of MMP9 protein]|naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of and results in increased secretion of MMP9 protein]|naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of MMP9 mrna],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
228,1271777,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Naringenin results in decreased expression of and results in decreased activity of MMP9 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
229,1271778,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,9606.0,Homo sapiens (human),Naringenin results in decreased expression of MMP9 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
230,1271779,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of MSH2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
231,1271780,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4654,MYOD1,https://ctdbase.org/detail.go?type=gene&acc=4654,,,4654.0,MYOD1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of MYOD1 mrna|naringenin metabolite results in increased expression of MYOD1 mrna|naringenin results in increased expression of MYOD1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of MYOD1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
232,1271781,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,79923,NANOG,https://ctdbase.org/detail.go?type=gene&acc=79923,,,79923.0,NANOG,9606.0,Homo sapiens (human),Naringenin results in decreased expression of NANOG protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
233,1271782,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4763,NF1,https://ctdbase.org/detail.go?type=gene&acc=4763,,,4763.0,NF1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of NF1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of NF1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
234,1271783,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,10116.0,Rattus norvegicus (Norway rat),Naringenin results in increased expression of PGR mRNA,,,PMID:10397250,https://www.ncbi.nlm.nih.gov/pubmed/10397250,10397250,,
235,1271955,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Naringenin results in increased expression of NFE2L2 mrna|[naringenin co-treated with paraquat] results in increased expression of NFE2L2 protein|naringenin results in increased expression of and affects the localization of NFE2L2 protein,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
236,1271956,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606.0,Homo sapiens (human),Naringenin results in increased activity of NFE2L2 protein|nfe2l2 protein affects the reaction [naringenin results in increased expression of GCLC protein]|nfe2l2 protein affects the reaction [naringenin results in increased expression of GCLM protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
237,1271957,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790.0,NFKB1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of NFKB1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of NFKB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
238,1271958,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein],,,PMID:10188978,https://www.ncbi.nlm.nih.gov/pubmed/10188978,10188978,,
239,1271959,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4795,NFKBIL1,https://ctdbase.org/detail.go?type=gene&acc=4795,,,4795.0,NFKBIL1,9606.0,Homo sapiens (human),Naringenin results in increased expression of NFKBIL1 protein|naringenin results in increased expression of NFKBIL1 mRNA,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
240,1271960,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4830,NME1,https://ctdbase.org/detail.go?type=gene&acc=4830,,,4830.0,NME1,9606.0,Homo sapiens (human),Naringenin results in increased expression of NME1 mrna|naringenin results in increased expression of NME1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
241,1271961,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),"Hemin promotes the reaction [naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]]|naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 mrna]|naringenin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of NOS2 protein]",,,PMID:15316927,https://www.ncbi.nlm.nih.gov/pubmed/15316927,15316927,,
242,1271962,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 mrna],,,PMID:10188978|PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/10188978|https://www.ncbi.nlm.nih.gov/pubmed/18274639,10188978|18274639,,
243,1271963,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of NOS2 protein],,,PMID:12512693|PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/12512693|https://www.ncbi.nlm.nih.gov/pubmed/18274639,12512693|18274639,,
244,1272147,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [[lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of nitric oxide],,,PMID:10188978,https://www.ncbi.nlm.nih.gov/pubmed/10188978,10188978,,
245,1272148,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606.0,Homo sapiens (human),Naringenin results in increased expression of NQO1 mrna|[paraquat co-treated with naringenin] results in increased expression of NQO1 mrna|naringenin results in increased expression of NQO1 protein,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
246,1272149,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606.0,Homo sapiens (human),Naringenin results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
247,1272150,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [pyruvaldehyde results in increased cleavage of PARP1 protein],,,PMID:31254498,https://www.ncbi.nlm.nih.gov/pubmed/31254498,31254498,,
248,1272151,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142.0,PARP1,9606.0,Homo sapiens (human),Naringenin results in increased cleavage of PARP1 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
249,1272152,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PCNA mrna|[naringenin co-treated with bisphenol A] results in increased expression of PCNA mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
250,1272153,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5226,PGD,https://ctdbase.org/detail.go?type=gene&acc=5226,,,5226.0,PGD,9606.0,Homo sapiens (human),Naringenin results in decreased activity of PGD protein,,,PMID:25130191,https://www.ncbi.nlm.nih.gov/pubmed/25130191,25130191,,
251,1272154,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606.0,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PGR mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
252,1272155,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,55367,PIDD1,https://ctdbase.org/detail.go?type=gene&acc=55367,,,55367.0,PIDD1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PIDD1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of PIDD1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
253,1272156,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606.0,Homo sapiens (human),Naringenin results in increased expression of PON1 mRNA,,,PMID:15169886,https://www.ncbi.nlm.nih.gov/pubmed/15169886,15169886,,
254,1272314,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5465,PPARA,https://ctdbase.org/detail.go?type=gene&acc=5465,,,5465.0,PPARA,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARA protein]|het0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARA protein]]|naringenin inhibits the reaction [glucose results in decreased expression of PPARA protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
255,1272315,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,100136658,PPARB,https://ctdbase.org/detail.go?type=gene&acc=100136658,,,100136658.0,,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [glucose results in decreased expression of PPARB protein]|naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARB protein]|het0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARB protein]],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
256,1272316,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10090.0,Mus musculus (house mouse),HET0016 inhibits the reaction [naringenin inhibits the reaction [glucose results in decreased expression of PPARG protein]]|naringenin inhibits the reaction [glucose results in decreased expression of PPARG protein]|naringenin inhibits the reaction [[streptozocin co-treated with dietary fats co-treated with carboxymethylcellulose sodium] results in decreased expression of PPARG protein],,,PMID:31063766,https://www.ncbi.nlm.nih.gov/pubmed/31063766,31063766,,
257,1272317,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased expression of PPARG protein]|naringenin inhibits the reaction [streptozocin results in decreased expression of PPARG mrna],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
258,1272318,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8493,PPM1D,https://ctdbase.org/detail.go?type=gene&acc=8493,,,8493.0,PPM1D,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of PPM1D mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of PPM1D mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
259,1272319,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5052,PRDX1,https://ctdbase.org/detail.go?type=gene&acc=5052,,,5052.0,PRDX1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of PRDX1 protein|naringenin results in decreased expression of PRDX1 mRNA,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
260,1272320,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PRKCA mrna|[naringenin co-treated with bisphenol A] results in increased expression of PRKCA mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
261,1272321,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCA protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
262,1272322,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5579,PRKCB,https://ctdbase.org/detail.go?type=gene&acc=5579,,,5579.0,PRKCB,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCB protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
263,1272496,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5582,PRKCG,https://ctdbase.org/detail.go?type=gene&acc=5582,,,5582.0,PRKCG,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate affects the localization of PRKCG protein],,,PMID:25866363,https://www.ncbi.nlm.nih.gov/pubmed/25866363,25866363,,
264,1272497,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8842,PROM1,https://ctdbase.org/detail.go?type=gene&acc=8842,,,8842.0,PROM1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of PROM1 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
265,1272498,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5664,PSEN2,https://ctdbase.org/detail.go?type=gene&acc=5664,,,5664.0,PSEN2,9606.0,Homo sapiens (human),[naringenin results in increased phosphorylation of and results in increased activity of ESR1 protein] which results in increased expression of PSEN2 mRNA,,,PMID:24586459,https://www.ncbi.nlm.nih.gov/pubmed/24586459,24586459,,
266,1272499,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5728,PTEN,https://ctdbase.org/detail.go?type=gene&acc=5728,,,5728.0,PTEN,9606.0,Homo sapiens (human),Naringenin results in increased expression of PTEN mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of PTEN mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
267,1272500,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606.0,Homo sapiens (human),Naringenin results in increased expression of PTGS1 mRNA,,,PMID:24561720,https://www.ncbi.nlm.nih.gov/pubmed/24561720,24561720,,
268,1272501,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of PTGS2 mrna],,,PMID:21341175,https://www.ncbi.nlm.nih.gov/pubmed/21341175,21341175,,
269,1272502,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of PTTG1 mrna|naringenin metabolite results in increased expression of PTTG1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
270,1272503,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5925,RB1,https://ctdbase.org/detail.go?type=gene&acc=5925,,,5925.0,RB1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of RB1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
271,1272504,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970.0,RELA,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides affects the localization of and results in increased activity of RELA protein],,,PMID:18274639,https://www.ncbi.nlm.nih.gov/pubmed/18274639,18274639,,
272,1272505,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,56475,RPRM,https://ctdbase.org/detail.go?type=gene&acc=56475,,,56475.0,RPRM,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of RPRM mrna|naringenin metabolite results in increased expression of RPRM mrna|[naringenin co-treated with bisphenol A] results in increased expression of RPRM mrna|naringenin results in increased expression of RPRM mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
273,1272629,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,57521,RPTOR,https://ctdbase.org/detail.go?type=gene&acc=57521,,,57521.0,RPTOR,9606.0,Homo sapiens (human),Naringenin results in increased expression of RPTOR mrna|naringenin results in increased expression of RPTOR protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
274,1272630,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased expression of SERPINE1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
275,1272631,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,83667,SESN2,https://ctdbase.org/detail.go?type=gene&acc=83667,,,83667.0,SESN2,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of SESN2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of SESN2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
276,1272632,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6462,SHBG,https://ctdbase.org/detail.go?type=gene&acc=6462,,,6462.0,SHBG,9606.0,Homo sapiens (human),Naringenin binds to SHBG protein,,,PMID:25349334,https://www.ncbi.nlm.nih.gov/pubmed/25349334,25349334,,
277,1272633,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6476,SI,https://ctdbase.org/detail.go?type=gene&acc=6476,,,6476.0,SI,9606.0,Homo sapiens (human),Naringenin binds to and results in decreased activity of SI protein|naringenin results in decreased activity of SI protein,,,PMID:24412302,https://www.ncbi.nlm.nih.gov/pubmed/24412302,24412302,,
278,1272634,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6477,SIAH1,https://ctdbase.org/detail.go?type=gene&acc=6477,,,6477.0,SIAH1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of SIAH1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
279,1272635,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,23411,SIRT1,https://ctdbase.org/detail.go?type=gene&acc=23411,,,23411.0,SIRT1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of SIRT1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of SIRT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
280,1272636,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLC16A1 protein results in increased uptake of benzoic acid],,,PMID:17976262,https://www.ncbi.nlm.nih.gov/pubmed/17976262,17976262,,
281,1272637,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6566,SLC16A1,https://ctdbase.org/detail.go?type=gene&acc=6566,,,6566.0,SLC16A1,10116.0,Rattus norvegicus (Norway rat),[naringenin results in decreased activity of SLC16A1 protein] which results in decreased uptake of sodium oxybate,,,PMID:17108059,https://www.ncbi.nlm.nih.gov/pubmed/17108059,17108059,,
282,1272638,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLC2A1 protein affects the transport of glucose]|naringenin results in decreased activity of SLC2A1 protein,,,PMID:14642735,https://www.ncbi.nlm.nih.gov/pubmed/14642735,14642735,,
283,1272820,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6517,SLC2A4,https://ctdbase.org/detail.go?type=gene&acc=6517,,,6517.0,SLC2A4,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [streptozocin results in decreased expression of SLC2A4 protein]|naringenin inhibits the reaction [streptozocin results in decreased expression of SLC2A4 mrna],,,PMID:29223569,https://www.ncbi.nlm.nih.gov/pubmed/29223569,29223569,,
284,1272821,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6523,SLC5A1,https://ctdbase.org/detail.go?type=gene&acc=6523,,,6523.0,SLC5A1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLC5A1 protein results in increased uptake of methylglucoside],,,PMID:17495124,https://www.ncbi.nlm.nih.gov/pubmed/17495124,17495124,,
285,1272822,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6531,SLC6A3,https://ctdbase.org/detail.go?type=gene&acc=6531,,,6531.0,SLC6A3,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of SLC6A3 mrna]|naringenin results in decreased expression of SLC6A3 mRNA,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
286,1272823,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10599,SLCO1B1,https://ctdbase.org/detail.go?type=gene&acc=10599,,,10599.0,SLCO1B1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLCO1B1 protein results in increased import of sulfobromophthalein],,,PMID:22394605,https://www.ncbi.nlm.nih.gov/pubmed/22394605,22394605,,
287,1272824,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,28234,SLCO1B3,https://ctdbase.org/detail.go?type=gene&acc=28234,,,28234.0,SLCO1B3,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLCO1B3 protein results in increased import of sulfobromophthalein],,,PMID:22394605,https://www.ncbi.nlm.nih.gov/pubmed/22394605,22394605,,
288,1272825,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [SLCO2B1 protein results in increased uptake of estrone sulfate],,,PMID:23794501,https://www.ncbi.nlm.nih.gov/pubmed/23794501,23794501,,
289,1272826,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6615,SNAI1,https://ctdbase.org/detail.go?type=gene&acc=6615,,,6615.0,SNAI1,9606.0,Homo sapiens (human),Naringenin results in decreased expression of SNAI1 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
290,1272827,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6591,SNAI2,https://ctdbase.org/detail.go?type=gene&acc=6591,,,6591.0,SNAI2,9606.0,Homo sapiens (human),Naringenin results in decreased expression of SNAI2 protein,,,PMID:30431227,https://www.ncbi.nlm.nih.gov/pubmed/30431227,30431227,,
291,1272828,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,10116.0,Rattus norvegicus (Norway rat),Naringenin results in increased expression of SNCA mrna|naringenin inhibits the reaction [paraquat results in increased expression of SNCA mrna],,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
292,1272829,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,9021,SOCS3,https://ctdbase.org/detail.go?type=gene&acc=9021,,,9021.0,SOCS3,9606.0,Homo sapiens (human),Naringenin results in increased expression of SOCS3 mrna|naringenin results in increased expression of SOCS3 protein,,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
293,1273004,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090.0,Mus musculus (house mouse),Naringenin results in decreased expression of SOD1 protein,,,PMID:28395574,https://www.ncbi.nlm.nih.gov/pubmed/28395574,28395574,,
294,1273005,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in increased expression of SOD1 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
295,1273006,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [glucose results in decreased expression of SOD2 mrna],,,PMID:23192364,https://www.ncbi.nlm.nih.gov/pubmed/23192364,23192364,,
296,1273007,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6657,SOX2,https://ctdbase.org/detail.go?type=gene&acc=6657,,,6657.0,SOX2,9606.0,Homo sapiens (human),Naringenin results in decreased expression of SOX2 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
297,1273008,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in increased expression of SPP1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
298,1273009,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,100301543,ST1A8,https://ctdbase.org/detail.go?type=gene&acc=100301543,,,100301543.0,,9986.0,Oryctolagus cuniculus (rabbit),Mefenamic acid inhibits the reaction [ST1A8 protein results in increased sulfation of naringenin],,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
299,1273010,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6772,STAT1,https://ctdbase.org/detail.go?type=gene&acc=6772,,,6772.0,STAT1,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of STAT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
300,1273011,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Naringenin results in decreased phosphorylation of STAT3 protein,,,PMID:27468969,https://www.ncbi.nlm.nih.gov/pubmed/27468969,27468969,,
301,1273012,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [IL6 protein promotes the reaction [STAT3 protein results in increased expression of ccl2]]|naringenin inhibits the reaction [IL6 protein results in increased phosphorylation of and results in increased activity of STAT3 protein],,,PMID:23782265,https://www.ncbi.nlm.nih.gov/pubmed/23782265,23782265,,
302,1273013,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606.0,Homo sapiens (human),Mefenamic acid inhibits the reaction [SULT1A1 protein results in increased sulfation of naringenin],,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
303,1273132,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,6818,SULT1A3,https://ctdbase.org/detail.go?type=gene&acc=6818,,,6818.0,SULT1A3,9606.0,Homo sapiens (human),SULT1A3 protein results in increased sulfation of naringenin,,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
304,1273133,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,10474,TADA3,https://ctdbase.org/detail.go?type=gene&acc=10474,,,10474.0,TADA3,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of TADA3 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
305,1273134,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040.0,TGFB1,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [carbon tetrachloride results in increased expression of TGFB1 protein],,,PMID:23845967,https://www.ncbi.nlm.nih.gov/pubmed/23845967,23845967,,
306,1273135,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7054,TH,https://ctdbase.org/detail.go?type=gene&acc=7054,,,7054.0,TH,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [paraquat results in decreased expression of TH protein]|naringenin results in decreased expression of TH protein,,,PMID:34655599,https://www.ncbi.nlm.nih.gov/pubmed/34655599,34655599,,
307,1273136,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TNF mrna|naringenin metabolite results in increased expression of TNF mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNF mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
308,1273137,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [tetradecanoylphorbol acetate results in increased secretion of TNF protein],,,PMID:19135038,https://www.ncbi.nlm.nih.gov/pubmed/19135038,19135038,,
309,1273138,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090.0,Mus musculus (house mouse),Naringenin inhibits the reaction [lipopolysaccharides results in increased expression of TNF],,,PMID:18720166,https://www.ncbi.nlm.nih.gov/pubmed/18720166,18720166,,
310,1273139,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [TNF protein results in decreased expression of and results in decreased activity of HMOX1 protein]|naringenin inhibits the reaction [TNF protein results in increased expression of SPP1 mrna]|naringenin inhibits the reaction [TNF protein results in increased phosphorylation of AKT1 protein]|naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein]|naringenin results in decreased activity of TNF protein|zinc protoporphyrin inhibits the reaction [naringenin results in decreased activity of TNF protein]|naringenin inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein]|naringenin inhibits the reaction [TNF protein results in increased expression of SERPINE1 mrna]|naringenin inhibits the reaction [TNF protein results in decreased expression of HMOX1 mrna],,,PMID:22709785,https://www.ncbi.nlm.nih.gov/pubmed/22709785,22709785,,
311,1273140,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TNFRSF10B mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNFRSF10B mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
312,1273283,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8793,TNFRSF10D,https://ctdbase.org/detail.go?type=gene&acc=8793,,,8793.0,TNFRSF10D,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TNFRSF10D mrna|[naringenin co-treated with bisphenol A] results in increased expression of TNFRSF10D mrna|naringenin results in increased expression of TNFRSF10D mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
313,1273284,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Naringenin inhibits the reaction [hydrogen peroxide results in increased phosphorylation of and results in increased activity of TP53 protein],,,PMID:15795422,https://www.ncbi.nlm.nih.gov/pubmed/15795422,15795422,,
314,1273285,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Naringenin results in increased expression of and results in increased phosphorylation of TP53 protein,,,PMID:27838343,https://www.ncbi.nlm.nih.gov/pubmed/27838343,27838343,,
315,1273286,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,9606.0,Homo sapiens (human),Naringenin results in increased expression of TP53 mrna|[tamoxifen co-treated with naringenin] results in increased expression of TP53 mRNA,,,PMID:30153467,https://www.ncbi.nlm.nih.gov/pubmed/30153467,30153467,,
316,1273287,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,63970,TP53AIP1,https://ctdbase.org/detail.go?type=gene&acc=63970,,,63970.0,TP53AIP1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TP53AIP1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53AIP1 mrna|naringenin metabolite results in increased expression of TP53AIP1 mrna|naringenin results in increased expression of TP53AIP1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
317,1273288,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7159,TP53BP2,https://ctdbase.org/detail.go?type=gene&acc=7159,,,7159.0,TP53BP2,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP53BP2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
318,1273289,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,8626,TP63,https://ctdbase.org/detail.go?type=gene&acc=8626,,,8626.0,TP63,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP63 mrna|naringenin metabolite results in increased expression of TP63 mrna|naringenin results in increased expression of TP63 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TP63 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
319,1273290,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7161,TP73,https://ctdbase.org/detail.go?type=gene&acc=7161,,,7161.0,TP73,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in increased expression of TP73 mrna|naringenin metabolite results in increased expression of TP73 mrna|naringenin results in increased expression of TP73 mrna|[naringenin co-treated with bisphenol A] results in increased expression of TP73 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
320,1273291,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7173,TPO,https://ctdbase.org/detail.go?type=gene&acc=7173,,,7173.0,TPO,10116.0,Rattus norvegicus (Norway rat),Naringenin results in decreased activity of TPO protein,,,PMID:26884060,https://www.ncbi.nlm.nih.gov/pubmed/26884060,26884060,,
321,1273442,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7186,TRAF2,https://ctdbase.org/detail.go?type=gene&acc=7186,,,7186.0,TRAF2,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TRAF2 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of TRAF2 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
322,1273443,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,80036,TRPM3,https://ctdbase.org/detail.go?type=gene&acc=80036,,,80036.0,TRPM3,9606.0,Homo sapiens (human),Naringenin results in decreased activity of TRPM3 protein,,,PMID:25361167,https://www.ncbi.nlm.nih.gov/pubmed/25361167,25361167,,
323,1273444,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7248,TSC1,https://ctdbase.org/detail.go?type=gene&acc=7248,,,7248.0,TSC1,9606.0,Homo sapiens (human),[naringenin co-treated with bisphenol A] results in increased expression of TSC1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
324,1273445,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7350,UCP1,https://ctdbase.org/detail.go?type=gene&acc=7350,,,7350.0,UCP1,10116.0,Rattus norvegicus (Norway rat),Naringenin inhibits the reaction [dietary fats results in decreased expression of UCP1 mrna],,,PMID:30372826,https://www.ncbi.nlm.nih.gov/pubmed/30372826,30372826,,
325,1273446,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,9606.0,Homo sapiens (human),UGT1A1 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
326,1273447,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54658,UGT1A1,https://ctdbase.org/detail.go?type=gene&acc=54658,,,54658.0,UGT1A1,10090.0,Mus musculus (house mouse),Naringenin results in increased expression of UGT1A1 mRNA,,,PMID:31621310,https://www.ncbi.nlm.nih.gov/pubmed/31621310,31621310,,
327,1273448,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54575,UGT1A10,https://ctdbase.org/detail.go?type=gene&acc=54575,,,54575.0,UGT1A10,9606.0,Homo sapiens (human),UGT1A10 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
328,1273449,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54577,UGT1A7,https://ctdbase.org/detail.go?type=gene&acc=54577,,,54577.0,UGT1A7,9606.0,Homo sapiens (human),UGT1A7 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
329,1273450,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54576,UGT1A8,https://ctdbase.org/detail.go?type=gene&acc=54576,,,54576.0,UGT1A8,9606.0,Homo sapiens (human),UGT1A8 protein results in increased glucuronidation of naringenin,,,PMID:14557274,https://www.ncbi.nlm.nih.gov/pubmed/14557274,14557274,,
330,1273451,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,54600,UGT1A9,https://ctdbase.org/detail.go?type=gene&acc=54600,,,54600.0,UGT1A9,9606.0,Homo sapiens (human),UGT1A9 protein results in increased glucuronidation of naringenin,,,PMID:14557274|PMID:18816295,https://www.ncbi.nlm.nih.gov/pubmed/14557274|https://www.ncbi.nlm.nih.gov/pubmed/18816295,14557274|18816295,,
331,1273452,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606.0,Homo sapiens (human),UGT2B15 protein results in increased metabolism of naringenin,,,PMID:7835232,https://www.ncbi.nlm.nih.gov/pubmed/7835232,7835232,,
332,1273570,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606.0,Homo sapiens (human),UGT2B15 protein SNP results in increased metabolism of naringenin,,,PMID:12386133,https://www.ncbi.nlm.nih.gov/pubmed/12386133,12386133,,
333,1273571,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,10116.0,Rattus norvegicus (Norway rat),UGT2B15 protein results in increased metabolism of naringenin,,,PMID:7574722,https://www.ncbi.nlm.nih.gov/pubmed/7574722,7574722,,
334,1273572,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9986.0,Oryctolagus cuniculus (rabbit),"[cholesterol, dietary co-treated with naringenin] affects the expression of VCAM1 mRNA",,,PMID:11396955,https://www.ncbi.nlm.nih.gov/pubmed/11396955,11396955,,
335,1273573,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7490,WT1,https://ctdbase.org/detail.go?type=gene&acc=7490,,,7490.0,WT1,9606.0,Homo sapiens (human),Naringenin metabolite results in increased expression of WT1 mrna|[naringenin co-treated with bisphenol A] results in increased expression of WT1 mrna|[naringenin metabolite co-treated with bisphenol A] results in increased expression of WT1 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
336,1273574,439246,Comparative Toxicogenomics Database (CTD),Naringenin,C005273,naringenin,https://ctdbase.org/detail.go?type=chem&acc=C005273,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606.0,Homo sapiens (human),[naringenin metabolite co-treated with bisphenol A] results in decreased expression of XRCC5 mRNA,,,PMID:36235125,https://www.ncbi.nlm.nih.gov/pubmed/36235125,36235125,,
337,1283815,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,ESR2,https://www.dgidb.org/genes/ESR2,,,2100.0,ESR2,9606.0,Homo sapiens (human),,,,,,,,
338,1292713,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,CYP1B1,https://www.dgidb.org/genes/CYP1B1,,,1545.0,CYP1B1,9606.0,Homo sapiens (human),,,,,,,,
339,1300101,439246,BindingDB,Naringenin,23419,"(2S)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=23419,2394,Alpha-amylase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2394,"P0DUB6,P0DTE7,P0DTE8",,,,,,,,,PMID:18507367,https://www.ncbi.nlm.nih.gov/pubmed/18507367,18507367,,
340,1407491,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,,https://www.dgidb.org/genes/,,,,,,,,,,,,,,
341,1919391,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,CYP1A2,https://www.dgidb.org/genes/CYP1A2,,,1544.0,CYP1A2,9606.0,Homo sapiens (human),,,,,,,,
342,1978296,439246,Drug Gene Interaction database (DGIdb),Naringenin,,NARINGENIN,https://www.dgidb.org/drugs/NARINGENIN,,CYP2C19,https://www.dgidb.org/genes/CYP2C19,,,1557.0,CYP2C19,9606.0,Homo sapiens (human),,,,,,,,
